
11th National Volume‑Based Procurement Launches, 55 Drugs Cut Prices to Benefit Patients
On May 25, 2026, the 11th National Centralized Drug Procurement results were fully implemented across public hospitals nationwide, covering 55
Free Shipping on orders over $59
24/7 Customer Support
My Account
Home » Oncology Innovation » Bispecific Antibodies
We keep track of the latest news on global drug R&D, approvals, policies and market trends. Follow new drug progress and regulatory updates, and deliver authoritative and timely pharmaceutical information for professionals.

On May 25, 2026, the 11th National Centralized Drug Procurement results were fully implemented across public hospitals nationwide, covering 55

On May 22, 2026, the Japanese MHLW expert committee formally approved TeroMira, developed by Oncolys Biopharma, for esophageal cancer, making

On March 27, 2026, AstraZeneca announced tezepelumab injection (Tezspire®) received full NMPA approval in China for maintenance treatment of severe

Since the beginning of 2026, the global pharmaceutical industry has accelerated across drug R&D, clinical breakthroughs, regulatory approvals and technological